drugset / Trial / NCT01673399

Oxytocin Antagonist in Patients With Repeated Failure of Implantation

NCT01673399

RandomizedParallel-groupDouble-blindTreatment

Summary

In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.

Timeline

Start
2012-02
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atosiban Other / unclassified 18 mg Intravenous